Table 2. Performance of modified-EUCAST rapid direct AST compared with conventional AST

Ann Clin Microbiol 2020;23:125-134. Performance of Modified-EUCAST Rapid Direct Antimicrobial Susceptibility Testing on Clinical Urine Samples

Table 2. Performance of modified-EUCAST rapid direct AST compared with conventional AST

Antimicrobial agents	Total	CA		MnE		ME		VME
Antimicrobial agents	Total	No.	(%)	No.	(%)	No.	(%)	No.	(%)
Ampicillin	103	99	(96.1)	3	(2.9)	0	(0)	1	(1.0)
Piperacillin-tazobactam	103	94	(91.3)	6	(5.8)	0	(0)	3	(2.9)
Cefazolin	103	98	(95.1)	0	(0)	1	(1.0)	4	(3.9)
Aztreonam	103	96	(93.2)	5	(4.8)	1	(1.0)	1	(1.0)
Ceftazidime	103	89	(86.4)	13	(12.6)	1	(1.0)	0	(0)
Cefotaxime	103	97	(94.2)	5	(4.8)	1	(1.0)	0	(0)
Cefoxitin	103	94	(91.2)	9	(8.7)	0	(0)	0	(0)
Cefepime	103	94	(91.3)	6	(5.8)	3	(2.9)	0	(0)
Ertapenem	103	100	(97.1)	2	(1.9)	0	(0)	1	(1.0)
Imipenem	103	96	(93.2)	6	(5.8)	0	(0)	1	(1.0)
Gentamicin	103	101	(98.1)	2	(1.9)	0	(0)	0	(0)
Amikacin	103	101	(98.1)	1	(1.0)	1	(1.0)	0	(0)
Ciprofloxacin	103	88	(85.4)	15	(14.6)	0	(0)	0	(0)
Cotrimoxazole	103	100	(95.1)	1	(1.0)	0	(0)	2	(1.9)
Tigecycline	103	95	(91.3)	2	(1.9)	1	(1.0)	5	(4.9)
TOTAL	1,545	1,442	(93.3)	76	(4.9)	9	(0.6)	18	(1.2)

Abbreviation: EUCAST, European committee on antimicrobial susceptibility testing; AST, antimicrobial susceptibility test; CA, categorical agreement; MnE, minor error; ME, major error; VME, very major error.